![]() Murphy, eds.), Academic Press, New York, pp. O., 1979, Monoamine Oxidase: Structure, Function, and Altered Functions, (T. Urwyler, S., and Von Wartburg, J.-P., 1980, Biochem. Glover, V., Sandler, M., Owen, F., and Riley, G. Sandier, eds.), Raven Press, New York, pp. Advances in Biochemical Psychopharmacology, Volume 5 (E. Kinemuchi, H., Wakui, Y., and Kamijo, K., 1980, J. L., 1979, Monoamine Oxidase: Structure, Function, and Altered Functions (T. (eds.), 1976, Monoamine Oxidase and Its Inhibition, Elsevier, Amsterdam.ĭiez, J. J., Lee, G., Laster, L., and Robinson, J. Markert, ed.), Academic Press, New York, pp. Schröder, ed.), Springer-Verlag, Berlin, pp. B., 1973, Genetics and Mutagenesis of Fish (J. Venkov, L., Rosenthal, L., and Manolova, M., 1976, Brain Res. Pasantes-Morales, H., Klethi, J., Urban, P. M., Blomstrand, C., and Hamberger, A., 1971, J. Hazama, H., and Uchimura, H., 1970, Biochim. (ed.), 1975, Isozymes, Academic Press, New York.Įrwin, V. Dean, eds.), North-Holland, Amsterdam, pp. T., 1975, Lysosomes in Biology and Pathology (J. (ed.), 1976, Isoelectric Focusing, Academic Press, New York. (eds), 1975, Isoelectric Focusing, Butterworths, London.Ĭastsimpoolas, N. B., 1972, Chromatographie Systems Maintainance and Troubleshooting, Academic Press, New York.Īrbutnot, J. (eds.), 1976, Chromatographic and Electrophoretic Techniques, 4th ed., Heinemann Medical, Chicago. ![]() A., 1977, Handbook of Enzyme Electrophoresis in Human Genetics, North-Holland, Amsterdam. T., 1973, Electrophoretic Screening Procedures, Lea & Febiger, Philadelphia. R., 1971, Disc Electrophoresis and Related Techniques of Poly acrylamide Gel Electrophoresis, de Gruyter, Berlin. Currently, promising therapeutic alternatives using the angiotensin-converting enzyme 2 (ACE2) are being studied to treat COVID-19.ĬOVID-19 biotechnology encapsulation enzyme therapy microarray molecular modification of enzymes monitoring of immune response.IUPAC-IUB Commission on Biochemical Nomenclature, 1971, Biochem. In this growing field, research is still ongoing to solve current health problems such as COVID-19. These assays have gained popularity due to their high-throughput analysis capacity, their simplicity, and their potential to monitor the immune response of patients during enzyme therapies. This can be achieved by conventional techniques (ELISA) but also by new promising tools such as microarrays. For this reason, it is important to monitor serum immune response during treatment. However, enzymes present some challenges, such as short in vivo half-life, lack of targeted action and, in particular, patient immune system reaction against the enzyme. ![]() These treatments present several advantages compared to established therapeutic approaches thanks to their affinity and specificity properties. Treatments based on the catalytic activity of enzymes are able to convert a wide range of target molecules to restore the correct physiological metabolism. In recent years, enzymes have risen as promising therapeutic tools for different pathologies, from metabolic deficiencies, such as fibrosis conditions, ocular pathologies or joint problems, to cancer or cardiovascular diseases.
0 Comments
Leave a Reply. |